TY - JOUR
T1 - When Patients Write the Guidelines
T2 - Patient Panel Recommendations for the Treatment of Rheumatoid Arthritis
AU - Fraenkel, Liana
AU - Miller, Amy S.
AU - Clayton, Kelly
AU - Crow-Hercher, Rachelle
AU - Hazel, Shantana
AU - Johnson, Britt
AU - Rott, Leslie
AU - White, Whitney
AU - Wiedmeyer, Carole
AU - Montori, Victor M.
AU - Singh, Jasvinder A.
AU - Nowell, W. Benjamin
N1 - Publisher Copyright:
© 2015, American College of Rheumatology.
PY - 2016/1/1
Y1 - 2016/1/1
N2 - Objective How best to involve patients in the development of clinical practice guideline (CPG) recommendations is not known. We sought to determine the feasibility and value of developing CPG recommendations based on a voting panel composed entirely of patients, with the ultimate goal of comparing the patients' recommendations to ones developed by a physician-dominated voting panel on the same clinical questions. Methods Ten patients with rheumatoid arthritis completed 8 hours of training on evidence-based medicine and guideline development. They constituted a voting panel and, with 2 American College of Rheumatology staff with expertise in CPG development and a physician facilitator, subsequently met at a face-to-face meeting to develop recommendations. They applied the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology to formulate recommendations on 18 questions for which there was evidence warranting moderate or high confidence. Results The patient panel developed recommendations for 16 of the 18 questions; for the other 2, the panel thought there were insufficient data to support a recommendation. For 13 of the 16 questions, the patient panel recommended the same course of action as did the physician-dominated panel. Differences were due to how the 2 panels valued the balance between benefits and harms. Conclusion Patient and physician-dominated panels developed the same recommendations for most questions for which there was evidence warranting moderate to high confidence. Additional experiences are necessary to advance the evidence necessary to determine what panel composition is optimal to produce the best guidelines.
AB - Objective How best to involve patients in the development of clinical practice guideline (CPG) recommendations is not known. We sought to determine the feasibility and value of developing CPG recommendations based on a voting panel composed entirely of patients, with the ultimate goal of comparing the patients' recommendations to ones developed by a physician-dominated voting panel on the same clinical questions. Methods Ten patients with rheumatoid arthritis completed 8 hours of training on evidence-based medicine and guideline development. They constituted a voting panel and, with 2 American College of Rheumatology staff with expertise in CPG development and a physician facilitator, subsequently met at a face-to-face meeting to develop recommendations. They applied the Grading of Recommendations, Assessment, Development and Evaluation (GRADE) methodology to formulate recommendations on 18 questions for which there was evidence warranting moderate or high confidence. Results The patient panel developed recommendations for 16 of the 18 questions; for the other 2, the panel thought there were insufficient data to support a recommendation. For 13 of the 16 questions, the patient panel recommended the same course of action as did the physician-dominated panel. Differences were due to how the 2 panels valued the balance between benefits and harms. Conclusion Patient and physician-dominated panels developed the same recommendations for most questions for which there was evidence warranting moderate to high confidence. Additional experiences are necessary to advance the evidence necessary to determine what panel composition is optimal to produce the best guidelines.
UR - http://www.scopus.com/inward/record.url?scp=84956736781&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84956736781&partnerID=8YFLogxK
U2 - 10.1002/acr.22758
DO - 10.1002/acr.22758
M3 - Article
C2 - 26545701
AN - SCOPUS:84956736781
SN - 2151-464X
VL - 68
SP - 26
EP - 35
JO - Arthritis Care and Research
JF - Arthritis Care and Research
IS - 1
ER -